TrialPloS one2012

Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in her2-positive metastatic breast cancer.

Sae-Won Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.